Log in

9939 Kintor Pharmaceutical Ltd HKEX · China

Kintor Pharmaceutical (9939) news

Kintor Pharmaceutical Ltd is a public biotech or pharmaceutical company listed on HKEX under the ticker 9939, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Kintor Pharmaceutical news

We have not published a story on Kintor Pharmaceutical yet. When there is news, it will appear here.

Questions about Kintor Pharmaceutical

What is the ticker symbol of Kintor Pharmaceutical?

Kintor Pharmaceutical Ltd trades under the ticker 9939 on HKEX.

Where is Kintor Pharmaceutical listed?

Kintor Pharmaceutical Ltd is listed on HKEX.

Which country or territory is Kintor Pharmaceutical listed under?

Our directory records Kintor Pharmaceutical Ltd under China.

What does Kintor Pharmaceutical do?

Our directory classifies Kintor Pharmaceutical Ltd as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Kintor Pharmaceutical?

The ISIN recorded for Kintor Pharmaceutical Ltd is KYG5273B1077.

Does aibio.space cover Kintor Pharmaceutical?

aibio.space lists Kintor Pharmaceutical Ltd among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Kintor Pharmaceutical?

Companies in our directory listed in the same country and business area as Kintor Pharmaceutical: Daan Gene Co., Jacobio Pharmaceuticals Group Co., Chongqing Zhifei Biological Products Co., Hangzhou Tigermed Consulting Co., Frontier Biotechnologies, PegBio Co..

Investor discussion: Kintor Pharmaceutical

Members talk about Kintor Pharmaceutical (9939). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Kintor Pharmaceutical, newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

  2. Financings

    Share or debt issue: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

  3. Financings

    Share or debt issue: COMPLETION OF TOP-UP PLACING OF EXISTING SHARES AND SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

  4. Financings

    Share or debt issue: (1) TOP-UP PLACING OF EXISTING SHARES AND (2) SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

Press releases

Headlines of Kintor Pharmaceutical's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    VOLUNTARY ANNOUNCEMENT - RECEIPT OF NOTICE OF GRANT OF INVENTION PATENT FOR KT-939

  2. HKEXnews

    RESIGNATION OF CHIEF FINANCIAL OFFICER, JOINT COMPANY SECRETARY AND PROCESS AGENT, APPOINTMENT OF CHIEF FINANCIAL OFFICER AND APPOINTMENT OF PROCESS AGENT

  3. HKEXnews

    VOLUNTARY ANNOUNCEMENT - SUCCESSFUL COMPLETION OF LONG-TERM HUMAN SAFETY TRIAL OF KT-939

  4. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  5. HKEXnews

    UPDATE ON MEASURES AND ACTIONS TAKEN IN RESOLVING THE DISCLAIMER OF OPINION IN THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2025

  6. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, 18 JUNE 2026

  7. HKEXnews

    VOLUNTARY ANNOUNCEMENT - POSITIVE INTERIM RESULT IN LONG-TERM HUMAN SAFETY TRIAL OF KT-939 AND COMMENCING OF REGISTRATION APPLICATION FOR THE NEW RAW MATERIAL

  8. HKEXnews

    VOLUNTARY ANNOUNCEMENT - KX-826 PHASE III CLINICAL TRIAL AND COMBINATION THERAPY STUDY DATA FOR AGA PRESENTED AT THE 2026 WORLD CONGRESS FOR HAIR RESEARCH (WCHR 2026), AND WAS SELECTED AS AN OUTSTANDING POSTER

  9. HKEXnews

    VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER DR.YOUZHI TONG BY 2,512,500 SHARES

  10. HKEXnews

    RETIREMENT OF AUDITOR AND PROPOSED APPOINTMENT OF NEW AUDITOR

  11. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  12. HKEXnews

    VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE

  13. HKEXnews

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025

  14. HKEXnews

    VOLUNTARY ANNOUNCEMENT - PHASE III STAGE OF PIVOTAL CLINICAL TRIAL OF KX-826 TINCTURE 1.0% FOR THE TREATMENT OF MALE ADULT AGA IN CHINA REACHED PRIMARY ENDPOINT

  15. HKEXnews

    VOLUNTARY ANNOUNCEMENT - STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH CHICMAX IN RELATION TO KT-939

  16. HKEXnews

    VOLUNTARY ANNOUNCEMENT - STRATEGIC COOPERATION AGREEMENT WITH FONOW MEDICINE IN RELATION TO KT-939

  17. HKEXnews

    SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE VOLUNTARY ANNOUNCEMENT

  18. HKEXnews

    VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER DR.YOUZHI TONG BY 4,700,000 SHARES

  19. HKEXnews

    VOLUNTARY ANNOUNCEMENT - EXCLUSIVE SALES AGENCY AGREEMENT IN RELATION TO ANTI-HAIR LOSS FOAM PRODUCT

  20. HKEXnews

    (1) RESIGNATION OF NON-EXECUTIVE DIRECTOR; AND (2) APPOINTMENT OF NON-EXECUTIVE DIRECTOR

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:9939 on TradingView.

Listing details

Kintor Pharmaceutical Ltd is a public biotech or pharmaceutical company listed on HKEX under the ticker 9939, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Kintor Pharmaceutical Ltd
Ticker
9939
Listing
HKEX
Country or territory
China
Business scope
Biotechnology
ISIN
KYG5273B1077
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.